19 - 22 Oct 2025 | Las Vegas

Defeating the Costliest Complication of Cancer Therapy using At-Home Blood Monitoring

Speakers:

Toby Basey-Fisher CEOEntiaHealth Tech & Solutions
Health Tech & Solutions
Toby Basey-Fisher
CEOEntia

About this Session:

Febrile neutropenia remains the most common and costliest complication of cancer therapy with over $11 billion spent every year on its management. The introduction of Liberty, the world’s first at-home blood count analyzer for cancer patients has opened up a wealth of new opportunities to address febrile neutropenia care pathways. This talk introduces how world-leading institutions and oncologists are utilizing Liberty to enhance patient care in relation to this life-threatening complication.

About Us

HLTH Inc. is a dynamic community delivering unique value to the healthcare industry through a mix of unparalleled global events, inspirational content, and impact-driven initiatives.

USA Event Dates

  • 2026 | HLTH: Nov 15 – 18 | Las Vegas, NV | Register | Sponsor
  • 2027 | ViVE: Mar 14 – 17 | Nashville, TN | Register | Sponsor
  • 2027 | HLTH: Oct 17 – 20 | Las Vegas, NV
  • 2028 | ViVE: Apr 23 – 26 | Fort Lauderdale, FL
  • 2028 | HLTH: Nov 12 – 15 | Las Vegas, NV

Europe Event Dates

  • 2027 | HLTH Europe: Jun 21 – 24 | Amsterdam, NH | Register | Sponsor
  • 2028 | HLTH Europe: Jun 19 – 22 | Amsterdam

Important Notice on Hotel Scams

Any communication that claims to represent HLTH or any third party offering discounted hotel rooms or attendee lists is NOT AFFILIATED with HLTH and should be considered fraudulent. Please book your accommodations only through HLTH’s official channels to ensure authenticity and security.